Gadelha M, Gatto F, Wildemberg LE, Fleseriu M (2023) Cushing’s syndrome. Lancet 402(10418):2237–2252. https://doi.org/10.1016/S0140-6736(23)01961-X

Article  PubMed  Google Scholar 

Reincke M, Fleseriu M (2023) Cushing syndrome: a review. JAMA 330(2):170–181. https://doi.org/10.1001/jama.2023.11305

Article  CAS  PubMed  Google Scholar 

Barbot M, Zilio M, Scaroni C (2020) Cushing’s syndrome: overview of clinical presentation, diagnostic tools and complications. Best Pract Res Clin Endocrinol Metab 34(2):101380. https://doi.org/10.1016/j.beem.2020.101380

Article  CAS  PubMed  Google Scholar 

Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing’s syndrome: state of the art. Lancet Diabetes Endocrinol 4(7):611–629. https://doi.org/10.1016/S2213-8587(16)00086-3

Article  CAS  PubMed  Google Scholar 

Limumpornpetch P, Morgan AW, Tiganescu A, Baxter PD, Nyawira Nyaga V, Pujades-Rodriguez M, Stewart PM (2022) The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality. J Clin Endocrinol Metab 107(8):2377–2388. https://doi.org/10.1210/clinem/dgac265

Article  PubMed  PubMed Central  Google Scholar 

Valassi E (2022) Clinical presentation and etiology of Cushing’s syndrome: data from ERCUSYN. J Neuroendocrinol 34(8):e13114. https://doi.org/10.1111/jne.13114

Article  CAS  PubMed  Google Scholar 

Valassi E, Santos A, Yaneva M, Tóth M, Strasburger CJ, Chanson P, Webb SM (2011) The European registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165(3):383–392. https://doi.org/10.1530/EJE-11-0272

Article  CAS  PubMed  Google Scholar 

Hakami OA, Ahmed S, Karavitaki N (2021) Epidemiology and mortality of Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab 35(1):101521. https://doi.org/10.1016/j.beem.2021.101521

Article  CAS  PubMed  Google Scholar 

Ambrogio AG, De Martin M, Ascoli P, Cavagnini F, Pecori Giraldi F (2014) Gender-dependent changes in haematological parameters in patients with Cushing’s disease before and after remission. Eur J Endocrinol 170(3):393–400. https://doi.org/10.1530/EJE-13-0824

Article  CAS  PubMed  Google Scholar 

Detomas M, Deutschbein T, Tamburello M, Chifu I, Kimpel O, Sbiera S, Altieri B (2023) Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study. J Endocrinol Invest. https://doi.org/10.1007/s40618-023-02128-x

Article  PubMed  PubMed Central  Google Scholar 

Varricchio L, Geer EB, Martelli F, Mazzarini M, Funnell A, Bieker JJ, Migliaccio AR (2023) Patients with hypercortisolemic cushing disease possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis. Haematologica 108(4):1053. https://doi.org/10.3324/haematol.2021.280542

Article  CAS  PubMed  Google Scholar 

Gursoy A, Dogruk Unal A, Ayturk S, Karakus S, Izol AN, Bascil Tutuncu N, Guvener Demirag N (2006) Polycythemia as the first manifestation of Cushing’s disease. J Endocrinol Invest 29:742–744. https://doi.org/10.1007/BF03344186

Article  CAS  PubMed  Google Scholar 

Dusek T, Kastelan D, Solak M, Basic Kinda S, Aganovic I, Korsic M (2008) Polycythemia as the first manifestation of Cushing’s disease. J Endocrinol Invest 31:940–940. https://doi.org/10.1007/BF03346446

Article  CAS  PubMed  Google Scholar 

Masri-Iraqi H, Robenshtok E, Tzvetov G, Manistersky Y, Shimon I (2014) Elevated white blood cell counts in Cushing’s disease: association with hypercortisolism. Pituitary 17:436–440. https://doi.org/10.1007/s11102-013-0522-0

Article  PubMed  Google Scholar 

Szczepanek-Parulska E, Adamska M, Korda O, Kosicka W, Skowrońska D, Ruchała M (2021) Changes in complete blood count parameters influenced by endocrine disorders. Endokrynol Pol 72(3):261–270. https://doi.org/10.5603/EP.a2021.0059

Article  CAS  PubMed  Google Scholar 

Tatsi C, Boden R, Sinaii N, Keil M, Lyssikatos C, Belyavskaya E, Lodish MB (2018) Decreased lymphocytes and increased risk for infection are common in endogenous pediatric Cushing syndrome. Pediatr Res 83(2):431–437. https://doi.org/10.1038/pr.2017.278

Article  PubMed  Google Scholar 

Mangion J, Imbroll MG, Craus S, Vassallo J, Gruppetta M (2022) Epidemiology and blood parameter changes in Cushing’s syndrome—A population-based study. Hormones 21(3):467–476. https://doi.org/10.1007/s42000-022-00384-9

Article  PubMed  Google Scholar 

Lodish H, Flygare J, Chou S (2010) From stem cell to erythroblast: regulation of red cell production at multiple levels by multiple hormones. IUBMB Life 62(7):492–496. https://doi.org/10.1002/iub.322

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21(1):55–89. https://doi.org/10.1210/edrv.21.1.0389

Article  CAS  PubMed  Google Scholar 

Bauer A, Tronche F, Wessely O, Kellendonk C, Reichardt HM, Steinlein P, Beug H (1999) The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 13(22):2996–3002. https://doi.org/10.1101/gad.13.22.2996

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malgor LA, Torales PR, Klainer E, Barrios L, Blanc CC (1974) Effects of dexamethasone on bone marrow erythropoiesis. Horm Res 5(5):269–277. https://doi.org/10.1159/000178640

Article  CAS  PubMed  Google Scholar 

Golde DW, Bersch N, Cline MJ (1976) Potentiation of erythropoiesis in vitro by dexamethasone. J Clin Invest 57(1):57–62. https://doi.org/10.1172/JCI108269

Article  CAS  PubMed  PubMed Central  Google Scholar 

von Lindern M, Zauner W, Mellitzer G, Steinlein P, Fritsch G, Huber K, Beug H (1999) The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 94(2):550–559. https://doi.org/10.1182/blood.V94.2.550

Article  Google Scholar 

Ebert BL, Lee MM, Pretz JL, Subramanian A, Mak R, Golub TR, Sieff CA (2005) An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray. Blood 105(12):4620–4626. https://doi.org/10.1182/blood-2004-08-3313

Article  CAS  PubMed  PubMed Central  Google Scholar 

Narla A, Dutt S, McAuley JR, Al-Shahrour F, Hurst S, McConkey M, Ebert BL (2011) Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis. Blood 118(8):2296–2304. https://doi.org/10.1182/blood-2010-11-318543

Article  CAS  PubMed  PubMed Central  Google Scholar 

Varricchio L, Migliaccio AR (2014) The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis. Am J Blood Res 4(2):53

CAS  PubMed  PubMed Central  Google Scholar 

Falchi M, Varricchio L, Martelli F, Masiello F, Federici G, Zingariello M, Migliaccio AR (2015) Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion. Haematologica 100(2):178. https://doi.org/10.3324/haematol.2014.114405

Article  CAS  PubMed  PubMed Central  Google Scholar 

Srivastava AS, Kaushal S, Mishra R, Lane TA, Carrier E (2006) Dexamethasone facilitates erythropoiesis in murine embryonic stem cells differentiating into hematopoietic cells in vitro. Biochem Biophys Res Commun 346(2):508–516. https://doi.org/10.1016/j.bbrc.2006.05.130

Article  CAS  PubMed  Google Scholar 

King DJ, Koekebakker M, Barr RD (1987) Modulation of human erythropoiesis by hydrocortisone in vitro. Eur J Haematol 38(2):137–140. https://doi.org/10.1111/j.1600-0609.1987.tb01151.x

Article  CAS  PubMed  Google Scholar 

Voorhees JL, Powell ND, Moldovan L, Mo X, Eubank TD, Marsh CB (2013) Chronic restraint stress upregulates erythropoiesis through glucocorticoid stimulation. PLoS ONE 8(10):e77935. https://doi.org/10.1371/journal.pone.0077935

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirsch D, Shimon I, Manisterski Y, Aviran-Barak N, Amitai O, Nadler V, Tsvetov G (2018) Cushing’s syndrome: comparison between Cushing’s disease and adrenal Cushing’s. Endocrine 62:712–720. https://doi.org/10.1007/s12020-018-1709-y

Article  CAS  PubMed  Google Scholar 

Kebebew E (2021) Adrenal incidentaloma. N Engl J Med 384(16):1542–1551. https://doi.org/10.1056/NEJMcp2031112

Article  PubMed  Google Scholar 

Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, Dekkers OM (2023) European society of endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 189(1):G1–G42. https://doi.org/10.1093/ejendo/lvad066